include larger, differentiated intramucosal adenocarcinoma and undifferentiated adenocarcinoma less than 20 mm in diameter and without ulceration.
A 60-year-old Japanese woman visited a local hospital because of anorexia and body weight loss, and gastroscopy revealed gastric cancer. She was admitted to our hospital for the treatment of gastric cancer in October 2001. She had no history of malignant disease and no family history of cancer. Upper gastrointestinal endoscopy revealed irregular, depressed mucosa, type 0 IIc in accordance with the Japanese classifi cation of gastric carcinoma (JCGC) [4] in the large curvature of the lower gastric body (Fig. 1) . The diameter was approximately 1 cm, and there were no ulcer fi ndings. Endoscopic ultrasonography revealed this to be an intramucosal cancer, and computed tomography examination showed no distinct lymph node metastasis. Pathologically, signet-ring cell carcinoma was detected in the biopsy specimen. Laboratory results were within normal limits, and serum carcinoembryonic antigen (CEA) levels were normal. Wedge resection of the stomach with resection of a single lymph node (#4d) was performed in November 2001 (Fig. 2) . Histological examination revealed that signet-ring cell carcinoma was located in approximately one-third of the superficial portion of the mucosal layer and that carcinoma cells had not invaded into the muscularis mucosa (Fig.  3A, B) . The tumor was 13 mm in size. No lymphatic invasion, venous invasion (immunohistochemical staining with CD34 and D2-40), or ulcer scar was observed in the submucosal layer. Histologically, there was no fi brosis in the submucosal layer and no breakdown of the muscularis mucosa. The resection margin was clear of tumor cells. The single resected lymph node had metastatic cancer cells; these were also signet-ring cell car-
Introduction
Early gastric cancer (EGC) is defi ned as a gastric cancer localized to the mucosa or submucosa regardless of lymph node metastasis. Radical gastrectomy with regional lymphadenectomy is the gold-standard treatment for patients with EGC [1] . For intramucosal EGC with little risk of lymph node metastasis, endoscopic mucosal resection (EMR) has been accepted as a minimally invasive treatment modality. EMR is generally indicated for intramucosal differentiated adenocarcinoma less than 20 mm in diameter and without ulceration [2, 3] . Recently, several institutions have suggested that the indications for EMR should be expanded to cinoma. Immediately, additional distal gastrectomy with D2 lymph node dissection (regional lymph node dissection of all group 1 and group 2 nodes) was performed, with a Billroth-I reconstruction. The gastric body with the fi rst resection scar was histologically examined and there was no cancer lesion. Cancer cell metastasis was detected in nodes #4sb, #4d, and #6 (5/65), and this case was fi nally diagnosed as stage IB (T1N1M0) according to the JCGC. This patient is alive without recurrence 6 years after treatment.
Discussion
For intramucosal EGC with little risk of lymph node metastasis, EMR is accepted as a minimally invasive treatment modality. Undifferentiated intramucosal EGC is known to be more commonly associated with A B Fig. 1A, B . Gastroscopy revealed a depressed lesion in the large curvature of the lower gastric body (arrowheads). There were no ulcer fi ndings, and endoscopic ultrasonography showed that this was an intramucosal cancer. A Without dye; B dyeing with indigo carmine lymph node metastasis compared to differentiated intramucosal EGC [5, 6] , and the indications for EMR are limited to differentiated intramucosal EGC that is less than 20 mm and without ulceration. Gotoda et al. [3] reported that none of 141 patients with undifferentiated intramucosal EGC less than 20 mm in size without ulceration had lymph node metastasis. The upper limit of the 95% confi dence interval was 2.6%, which was considered to be suffi ciently large to exclude the possibility of lymph node metastasis. Some predictive factors for lymph node metastasis in undifferentiated EGC have been reported [7] [8] [9] [10] [11] . Previously, we retrospectively examined factors predictive of lymph node metastasis in 332 patients with undifferentiated EGC who underwent gastrectomy, including the present patient. Multivariate analysis showed that the presence of lymphatic-vascular involvement was signifi cantly correlated with the incidence of lymph node metastasis [8] . Abe et al. [7] reported that multivariate logistic regression analysis indicated that tumor size and lymphatic involvement were independent risk factors for lymph node metastasis. Abe et al. reported small undifferentiated intramucosal EGC cases with tumors 10, 12, and 20 mm in diameter without ulceration that had lymph node metastasis. These investigators concluded that EMR should not be indicated for undifferentiated EGC more than 10 mm in diameter.
Fewer lymphatic-vascular vessels are present in the mucosal layer than in the submucosal layer. D2-40 immunohistochemical staining has revealed that lymphatic vessels are most densely distributed in the muscularis mucosa layer of the gastric wall [12] . The cancer cells in the patient reported here were located in onethird of the mucosal layer and did not contact the muscularis mucosa. The process of cancer metastasis in this patient is diffi cult to conjecture. Circulating cancer cells may have played a role, as cancer cells have been identifi ed at the DNA level in the peripheral blood of patients with EGC [13] .
The expanded criteria of EMR for undifferentiated EGC are controversial. For further clarifi cation of this issue, prognostic data for patients with undifferentiated EGC treated by EMR are required.
